Outset Medical, Inc. (NASDAQ:OM) General Counsel John L. Brottem Sells 20,492 Shares

Outset Medical, Inc. (NASDAQ:OM) General Counsel John L. Brottem sold 20,492 shares of the firm’s stock in a transaction dated Monday, January 13th. The stock was sold at an average price of $0.81, for a total transaction of $16,598.52. Following the completion of the transaction, the general counsel now directly owns 205,028 shares in the company, valued at $166,072.68. This represents a 9.09 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Outset Medical Stock Down 12.2 %

Shares of OM traded down $0.11 during midday trading on Monday, reaching $0.81. 1,885,376 shares of the stock were exchanged, compared to its average volume of 2,853,379. The company has a current ratio of 6.49, a quick ratio of 5.04 and a debt-to-equity ratio of 4.12. The company’s 50 day moving average is $1.00 and its two-hundred day moving average is $1.43. The company has a market capitalization of $42.44 million, a P/E ratio of -0.29 and a beta of 2.05. Outset Medical, Inc. has a 52 week low of $0.44 and a 52 week high of $5.22.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. National Bank of Canada FI raised its holdings in shares of Outset Medical by 79.2% in the 3rd quarter. National Bank of Canada FI now owns 52,407 shares of the company’s stock valued at $35,000 after purchasing an additional 23,164 shares in the last quarter. Huntington National Bank raised its stake in Outset Medical by 46.2% in the third quarter. Huntington National Bank now owns 63,306 shares of the company’s stock worth $43,000 after buying an additional 20,000 shares in the last quarter. Vanguard Personalized Indexing Management LLC bought a new position in Outset Medical in the second quarter worth approximately $49,000. Point72 Asia Singapore Pte. Ltd. purchased a new stake in Outset Medical during the second quarter worth $259,000. Finally, Squarepoint Ops LLC boosted its position in Outset Medical by 74.1% during the 2nd quarter. Squarepoint Ops LLC now owns 80,300 shares of the company’s stock valued at $309,000 after acquiring an additional 34,187 shares in the last quarter.

Wall Street Analysts Forecast Growth

Separately, Royal Bank of Canada restated a “sector perform” rating and issued a $3.00 target price on shares of Outset Medical in a research note on Tuesday, January 7th.

About Outset Medical

Outset Medical, Inc, a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables.